Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
Exploring the sequence features determining amyloidosis in human antibody light chains | Scientific Reports
Systemic amyloidosis - The Lancet
Cardiac amyloidosis: An update on diagnosis and treatment | Cleveland Clinic Journal of Medicine
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management - ScienceDirect
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Journal of Lancaster General Health - Journal of Lancaster General Hospital
Cardiac amyloidosis: An underdiagnosed/underappreciated disease - ScienceDirect
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis | JACC: Cardiovascular Imaging
Systemic amyloidosis from A (AA) to T (ATTR): a review - Muchtar - 2021 - Journal of Internal Medicine - Wiley Online Library
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis | Haematologica
AL Amyloidosis | Amyloidosis Foundation
Frontiers | From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis
Diagnostics | Amyloidosis Center
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Cureus | Slip-Ups in the Diagnosis of Cardiac Amyloidosis: A Case Fatality in Point | Article
Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement | Haematologica
JCDD | Free Full-Text | Invasive and Non-Invasive Diagnostic Pathways in the Diagnosis of Cardiac Amyloidosis
Diagnostics | Free Full-Text | Multimodal Imaging and Biomarkers in Cardiac Amyloidosis
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Serum and tissue light-chains as disease biomarkers and targets for treatment in AL amyloidosis
Manni Mohyuddin on Twitter: "There were some simplifications here in this thread, but will be helpful for fellows interpreting these values, and for non-hematologists who place these consults! Thanks for reading, and